Broadcasts.com

OT Broadcast News

Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on the OTUK Editorial Board; and Gianni Bonadonna, MD, of Istituto Nazionale Tumori.

From the European Hematology Association 2010 Congress: For Patients with Follicular Lymphoma, Rituximab Maintenance Therapy Cuts Risk of Recurrence in Half (Phase III PRIMA Study)

Published: June 17, 2010, midnight
Duration: 8 minutes 12 seconds

Listed in: Health

OT Clinical Advisory Editor for Hematology/Oncology Mikkael Sekeres, MD, MS

Published: April 9, 2010, 12:05 a.m.
Duration: 12 minutes 18 seconds

Listed in: Health

OT Clinical Advisory Editor for Oncology Ramaswamy Govindan, MD

Published: April 9, 2010, midnight
Duration: 8 minutes 39 seconds

Listed in: Health

Treatment Recommendations for High- & Low-Risk Early Breast Cancer: New Data from EBCC 7, the European Breast Cancer Conference

Published: April 8, 2010, midnight
Duration: 9 minutes 40 seconds

Listed in: Health

Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!

Published: Oct. 13, 2009, 12:02 a.m.
Duration: 6 minutes 57 seconds

Listed in: Health

KRAS-Driven Selection of Molecular Therapy for Metastatic Colorectal Cancer: Choosing Between Bevacizumab, Cetuximab, Panitumomab, or a Combination

Published: Aug. 1, 2009, midnight
Duration: 3 minutes 39 seconds

Listed in: Health

OT Broadcast News

Straight Talk with Dr. Brian J. Bolwell: Values

Straight Talk with Dr. Brian J. Bolwell: Moments

September 2010

Multiple Myeloma: Big Survival Gains from Novel Agents 'in the Real World'

From the European Hematology Association 2010 Congress: For Patients with Follicular Lymphoma, Rituximab Maintenance Therapy Cuts Risk of Recurrence in Half (Phase III PRIMA Study)

OT Clinical Advisory Editor for Hematology/Oncology Mikkael Sekeres, MD, MS

OT Clinical Advisory Editor for Oncology Ramaswamy Govindan, MD

Treatment Recommendations for High- & Low-Risk Early Breast Cancer: New Data from EBCC 7, the European Breast Cancer Conference

Pregnancy & Breast Cancer: New Updates from EBCC 7, the European Breast Cancer Conference

Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome

The Disappointment of the NSABP C-08 Trial

Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!

Research Policy Expert: Overhaul Cancer Research Priorities Globally Now!

Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality

Advanced Biliary Cancer Controlled with Cetuximab Added to GEMOX

Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos

Stage IV Pancreatic Islet Cell Tumors: Sunitinib Doubles Progression-Free Survival in Phase III Study

KRAS-Driven Selection of Molecular Therapy for Metastatic Colorectal Cancer: Choosing Between Bevacizumab, Cetuximab, Panitumomab, or a Combination

CML: Hagop Kantarjian on Treating Patients with the T315I Mutation

Oropharyngeal Cancer: Better Outlook with HPV-Directed Therapies

Breast Cancer: St. Gallen Meeting Endorses Multi-Gene Assays for Refining Chemo Decision

The Smartest Oncologist in the World? Well, at least in the US!

Cancer-Related Fatigue

Bilateral Prophylactic Mastectomy for DCIS

10th European Congress on Perspectives in Lung Cancer, Brussels

More from the ASH Annual Meeting!

ASH Annual Meeting

NCRI Conference, ASCO Annual Meeting, and Perspectives in Lung Cancer European Congress